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1. Introduction 
Cyanine photosensitizing dyes have been studied for over 150 years and continue to be of 
interest in their biology and medicine. They have been shown to possess various biological 
activities, including antimicrobial, antioxidant, macrophage activating, and oxidative 
phosphorylation uncoupling activities (Hayami, 1984; Ushio et al., 2009; Ishihara & 
Fujisawa, 2007; Kunikata et al., 2002; Takeguchi et al., 1985). Some dyes have been used as 
immunomodulators to treat allergy and rheumatoid arthritis, cancer, and to promote wound 
healing (Trauner et al., 1998; Motoyoshi et al., 1991). Since cumulative evidence suggests an 
involvement of oxidative stress and neuroinflammation as the common feature in the 
pathogenesis of neurodegenerative disorders (Amor et al., 2010; Wolozin & Behl, 2000a, 
2000b), it would be reasonable to expect that cyanine dyes with anti-oxidative and anti-
inflammatory properties could protect the central nervous system from neuroinflammatory-
related brain insults. 
Recently, we screened more than 250 cyanine dyes for their neurotrophin-like activity and 
found that NK-4 and some other related compounds are potent neurotrophic agents for the 
promotion of growth and differentiation of neuronal rat adrenal pheochromocytoma cell 
line PC12. NK-4 is a divalent cationic pentamethine trinuclear cyanine dye that contains 
three quinolinium rings, N-alkyl side chains, and two iodine anions (Fig. 1A). Addition of 
NK-4 into the culture at nanomolar concentrations significantly augmented cell growth of 
PC12 cells in 3-day cultures (Fig. 1B). NK-4 also promoted nerve growth factor (NGF)-
primed neurite-outgrowth at micromolar and submicromolar concentrations (Fig. 1C). Since 
the intervention using neurotrophic or neuroprotective small molecules is thought to have 
potential for treating neurodegenerative disorders, we investigated the neuroprotective 
effects of NK-4 against neurotoxic insults in vitro and further evaluated its pharmacological 
effects using animal models of neurodegeneration, including ischemic stroke, cerebellar 
ataxia, and Alzheimer’s disease (AD).  
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In this chapter, we focus on the neuroprotective effects of NK-4 against oxidative damage in 
vitro and in vivo. We introduce the multipotent properties of NK-4, which may act in concert 
to attenuate the common pathological pathways of neurodegeneration, and discuss the 
potential use of NK-4 for neurodegenerative disease therapy.  
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(A) Chemical structure of NK-4. It was synthesized in HAYASHIBARA Co., Ltd. (B) The proliferative 
effect of NK-4 on PC12 cells. Cell growth was assessed by AlamarBlue® assay in 3-day cultures. (C) The 
promotive effect of NK-4 on NGF (5 ng/ml)-primed neurite-outgrowth in PC12 cells. Neurite-
outgrowth was evaluated by counting neurite-outgrowth positive cells in 3-day cultures. The cells were 
defined as positive when the length of the longest neurite was >2-fold longer than that of the cell body. 
Data are means ± SD (n=3). *P<0.05 and ** P<0.01 vs. control (no NK-4).  
Fig. 1. Chemical structure and neurotrophin-like effects of NK-4. 
2. In Vitro Properties of NK-4 
2.1 Free radical-scavenging activity 
As it has been known that some cyanine dyes show significant antioxidative property due to 
the extended π-electron conjugated system contained within the structure (Ishihara & 
Fujisawa, 2007), the free radical-scavenging capacity of NK-4 for superoxides, hydroxyl, and 
peroxy radicals was evaluated (Koya-Miyata et al., 2010). These radicals are produced in 
vivo in many experimental models of ischemia and reperfusion, and they are therefore 
generally regarded as the primary free radicals involved in oxidative stress-mediated injury. 
Half-maximal inhibitory concentrations (IC50) of NK-4 against these radicals are shown in 
Table 1.  
Ascorbate, a well-characterized free radical-scavenging agent, and edaravone were used as 
positive controls. Edaravone, also known as MCI-186, is a hydroxy radical scavenger, and 
has been used for acute phase stroke therapy in Japan (Abe & Kogure, 1988). NK-4 
displayed a direct and powerful hydroxyl radical-scavenging activity, significantly greater 
than those of ascorbate and edaravone. The scavenging activity for peroxy radicals was also 
potent in NK-4 and to a lesser extent in ascorbate. NK-4 and ascorbate acted on superoxides 
to a comparable extent; however, edaravone did not act on superoxides as previously 
reported (Tanaka, 2002). The highly reactive hydroxyl radical oxidizes cellular lipids, 
proteins, and DNA, leading to cell death, and is therefore highly detrimental (Gilgun-Sherki 
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et al., 2002). Accordingly, the antioxidants that effectively scavenge hydroxyl radicals and 
other free radicals should be able to eliminate oxidative injury (Barinaga, 1996), and NK-4 
could be one of such molecules. 
 
Compound 
IC50 (µM) 
Hydroxyl Radical Peroxy Radical Superoxide 
NK-4 7.6 ± 0.6 5.2 ± 2.5 107 ± 2.2 
Ascorbate 47.6 ± 0.2 30.5 ± 1.7 130 ± 24 
Edaravone 779 ± 18 181 ± 19 > 3,800 
Free radical-scavenging efficacy was evaluated in a cell-free in vitro system using ESR. Superoxides, 
hydroxyl radicals, and peroxy radicals were produced and stabilized in DMPO-hypoxanthine/XOD, 
DMPO-DTPA/H2O2/FeSO4 and DMPO-AAPH systems, respectively. The signal intensity of each 
radical was recorded in the presence or absence of test samples. The scavenging activity of the samples 
was expressed as IC50 against each radical. Means ± SD (n=3). Reproduced in part with permission from 
Biological & Pharmaceutical Bulletin Vol.33 No.11. Copyright [2010] Pharmaceutical Society of Japan. 
Table 1. Free radical-scavenging effects of NK-4 and other antioxidants. 
2.2 Neuroprotective effects against various cytotoxic stresses 
Neurotrophins, such as NGF or brain-derived neurotrophic factor (BDNF) regulate the 
growth, survival, and differentiation of central neurons (Blum & Konnerth, 2005). For 
example, NGF protects PC12 cells against 6-hydroxydopamine (6-OHDA)- and hydrogen 
peroxide (H2O2)-induced oxidative stress (Salinas et al., 2003; Wang et al., 2001). Since 
NK-4 displayed a remarkable neurotrophin-like activity, namely the promotion of cell 
growth and NGF-primed neurite-outgrowth in PC12 cells (Fig. 1B, 1C), we next examined 
whether NK-4 protects neuronal cells from oxidative or starvation stress (Ohta et al., 
2011). An acute oxidative stress challenge was induced by 2-hr treatment with H2O2 or 24-
hr treatment with 6-OHDA. These treatments cause a significant decrease in metabolic 
capacity, which reflects a decline in cell viability, and this is accompanied by an 
enhancement of apoptotic markers (Franco et al., 2010). Particularly, 6-OHDA has been 
widely used in experimental models of Parkinsion’s disease, and its neurotoxicity 
involves oxidative damage to catecholaminergic neurons via the generation of hydroxyl 
radicals, monoamine oxidase-mediated formation of H2O2, and mitochondrial generation 
of superoxide (Blum et al., 2001). 
Treatment of PC12 cells with H2O2 decreased cell viability to approximately 50% of 
control. In contrast, NK-4 at concentrations of 6 µM or above significantly protected the 
cells from the acute oxidative damage (Fig. 2A). NK-4 also attenuated 6-OHDA-induced 
oxidative stress in PC12 cells at nanomolar concentrations in a dose-dependent manner 
(Fig. 2B). Next we tested the effect of NK-4 on trophic factor depletion-induced cell death. 
Extended serum depletion in PC12 cells triggers ATP shortage, which results in 
mitochondrial reactive oxygen species (ROS) generation and activation of apoptotic 
pathways (Troy et al., 2001). NK-4 at submicromolar concentrations significantly 
increased cellular viability of PC12 cells over 3 days of serum starvation (Fig. 2C). These 
results suggest that the antioxidative effects of NK-4, together with its neurotrophic 
properties, engender strong survival signals in PC12 cells. 
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PC12 cells were seeded at a density of 2 х 104 cells/well and cultured in serum supplemented D-MEM 
for 24-hr at 37ºC in collagen-coated microplates. (A) H2O2 (200 µM) or (B) 6-OHDA (100 µM) was 
applied in the presence or absence of indicated concentrations of NK-4 and incubated for 2-hr or 24-hr, 
respectively. (C) After the pre-culture, serum-containing D-MEM was replaced with serum-free 
medium and the cells were cultured for additional 3 days. Cell viability was assessed by the 
AlamarBlue® method. Results are shown as means ± SD (n=3). *P<0.05 and **P<0.01 vs. no NK-4. 
Fig. 2. Protective effect of NK-4 from cytotoxic stresses in PC12 cells. 
2.3 Neuroprotective effect against β-amyloid (Aβ) toxicity 
Next, we determined whether NK-4 was effective against ǃ-amyloid (Aǃ)-induced 
neurotoxicity in vitro using PC12 cells (Ohta et al., 2010a). PC12 cells are reported to be 
highly sensitive to Aǃ peptide or the aggregated Aǃ25-35 fragment (Shearman et al., 1994). 
The viability of PC12 cells treated with 50 µM of aged Aǃ25-35 for 72-hr was about 25% 
compared with controls without Aǃ25-35 (Fig. 3A). NK-4 dose-dependently attenuated the 
cytotoxic effect of Aǃ25-35 and the effects were significant at doses over 60 nM. Aǃ peptides 
induce morphological changes associated with apoptotic cell death, such as somal 
shrinkage, plasma membrane blebbing, chromatin condensation, and nuclear fragmentation 
(Ivins et al., 1999). Nuclear staining by Hoechst 333442 dye demonstrated the typical nuclear 
fragmentation in Aǃ25-35–treated PC12 cells and this was clearly inhibited by the addition of 
NK-4 (Fig. 3B).  
Since PC12 cells undergoing Aǃ-mediated apoptosis produce large amounts of ROS due to 
deficits in mitochondrial function (Kadowaki et al., 2005), we next examined ROS generation 
in Aǃ25-35–treated PC12 cells (Fig. 3C). Compared with the control, the amounts of 
intracellular ROS significantly increased after addition of 50 µM Aǃ25-35 in 48-hr cultures, 
and 300 nM of NK-4 almost totally suppressed the ROS induction. Under normal culture 
conditions, NK-4 also decreased basal ROS levels in normal PC12 cells; however, the effect 
was not statistically significant. These data suggest that NK-4 attenuates Aǃ-mediated 
cytotoxicity by reducing the unfavorable ROS accumulation in PC12 cells, probably through 
the restoration of mitochondrial function. 
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(A) Aǃ25-35 was dissolved in saline and incubated at 37 °C for 4 days, which is termed an “aging” 
process. PC12 cells were treated with 50 µM aged Aǃ25-35 for 72-hr in the absence or presence of the 
indicated concentrations of NK-4. Cell viability was assessed by AlamarBlue® assay. Results are shown 
as means ± SD (n=3). **P<0.01 vs. no NK-4. (B) PC12 cells were treated as (A) and stained with Hoechst 
33342 dye. (C) PC12 cells were treated as (A), but for 48 hr and the amount of intracellularly produced 
ROS was assessed by H2DCF-DA dye fluorescence (ex.492nm/em.527nm). Results are shown as means 
± SD (n=3). **P<0.01 vs. no NK-4. 
Fig. 3. Cytoprotective effects of NK-4 on Aǃ25-35-induced cytotoxicity in PC12 cells. 
2.4 Intracellular signaling 
Neurotrophins act by binding to two kinds of plasma membrane receptors, the Trk receptor 
tyrosine kinases (Trks) and the p75 pan-neurotrophin receptor (p75NTR). There are several 
subtypes of Trk receptor kinases characterized by their specific affinities for different 
neurotrophins. NGF binds preferentially to TrkA, whereas BDNF and neutrophin-4/5 show 
a high affinity for TrkB (Berg et al., 1992). To address whether the effects of NK-4 are 
mediated by Trk activity, K252a, a non-specific inhibitor of Trks, was applied in growth 
assays of PC12 cells. Pretreatment with K252a dose-dependently inhibited NGF-induced cell 
growth, but did not inhibit growth induced by NK-4 (Fig. 4A). This suggests that NK-4 acts 
independently of TrkA activation in PC12 cells. A similar inhibitory profile of K252a was 
also found in the neurite-outgrowth of PC12 cells (data not shown). 
We next examined whether NK-4 activates phosphatidylinositol 3-kinase (PI3K) and its 
downstream signaling effector Akt. This cascade is implicated in survival signaling 
mediated by NGF in serum-deprived PC12 cells, and in neuritogenesis in PC12 cells (Martin 
et al., 2004; Kim et al., 2004). LY294002, a specific PI3K inhibitor (Vlahos et al., 1994), blocked 
the cell growth-promoting activity of both NK-4 and NGF (Fig. 4B). Also, as shown in figure 
4C, NK-4 strongly induced phosphorylation of Akt at Ser 473 in a time-dependent manner. 
The dose of NK-4 required for the induction of Akt phosphorylation was consistent with 
that required for promotion of PC12 cell growth. These results suggest that sequential 
activation of PI3K and its downstream signaling effector Akt are important for NK-4-
induced neurotrophic effects in PC12 cells. 
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(A, B) Effects of K252a or LY294002 on PC12 cell growth induced by NK-4 (bold line) or NGF (broken 
line). PC12 cells were preincubated in serum-free D-MEM with the indicated concentrations of K252a 
(A) or LY294002 (B) for 15 min. NK-4 (250 nM) or NGF (50 ng/ml) was added and the cells were further 
incubated for 72-hr. Cell viabilities were assessed by AlamarBlue® assay. Values are means ± SD (n=3). 
*P<0.05, **P<0.01 vs. control. (C) PC12 cells were treated with 250 nM NK-4 for the indicated times. 
Whole cell lysates were analyzed by Western blotting using an anti-phospho-Akt (Ser 473) mAb (upper) 
or an anti-Akt mAb (lower). (D) PC12 cells were treated with 400 µM H2O2 for 2-hr in the presence of 
the indicated concentrations of NK-4. Phospho-SAPK/JNK (upper) and SAPK/JNK (lower) were 
analyzed by Western blotting using whole cell lysates.  
Fig. 4. NK-4 alters phosphorylation of Akt and SAPK/JNK in a Trk-independent manner. 
On the other hand, we also found that the SAPK/JNK stress-induced signaling pathway 
was altered by NK-4. SAPK/JNK is a major cellular stress-responsive protein activated by 
oxidative stress. Activated SAPK/JNK translocates from the cytosol to the nucleus and 
regulates the activity of transcription factors such as c-Jun, ATF-2, p53, SMAD4, and Elk-1 
(Kyriakis & Avruch, 2001). PC12 cells treated with cytotoxic levels of H2O2 displayed 
augmented phosphorylation of SAPK/JNK, and this was attenuated by NK-4 in a 
concentration-dependent manner (Fig. 4D). This observation suggests that NK-4 might 
attenuate H2O2-induced cellular stress upstream of SAPK/JNK. 
2.5 Anti-aggregative effect on Aβ and tau 
To examine the mechanisms of NK-4-mediated protection from amyloid toxicity in neuronal 
cells, we evaluated the effect of NK-4 on fibrillization of Aǃ (Fig. 5), since oligomerized or 
aggregated Aǃ seems more toxic to neuronal cells (Lesne et al., 2006, Shearman et al., 1994). 
ThioflavinT (ThT) fluorescence is enhanced upon binding to Aǃ fibrils in proportion to the 
amount of fibrils in solution (Lashuel et al., 2002). Therefore, the effect of NK-4 on Aǃ fibril 
formation was evaluated using ThT (Fig. 5A). In the absence of NK-4, both Aǃ1-40 and Aǃ1-42 
solutions displayed greatly enhanced emission at 482 nm, which is characteristic for ThT 
bound to amyloid fibrils. Significant decreases in ThT fluorescence were detected in the 
presence of NK-4 at concentrations of 10 µM or higher against 100 µM of Aǃ. An equimolar 
concentration of NK-4 almost totally inhibited the increase in ThT fluorescence. Under 
electron microscopic observation, Aǃ1-42 formed long and dense fibrils after 3 days of 
incubation (Fig. 5B, upper). In contrast, Aǃ1-42 incubated with 10 µM of NK-4 produced 
fewer and shorter filaments in soluble assemblies (Fig. 5B, lower).  
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In addition to Aǃ deposition, intraneuronal tau aggregates in the brain is a hallmark of AD. 
Since the mutated tau transgenic mouse P301L exhibited a clear correlation between tau 
aggregates and neurodegeneration (Lewis et al., 2000), small molecule inhibition of tau 
aggregation is considered a potential therapeutic strategy, alongside Aǃ anti-aggregative 
strategy (Pickhardt et al., 2007). Self-aggregation of tau protein occurs in the presence of 
polyanions such as heparin or poly(Glu), and can be quantitatively assessed by thioflavin S 
(ThS) fluorescence (Friedhoff et al., 1998). Therefore, we evaluated the inhibitory effect of 
NK-4 on tau aggregation using recombinant human tau-352 protein (0N3R variant, 15 µM) 
and heparin (2.5 µM) (Fig. 5C). As a result, NK-4 reduced ThS fluorescence in a dose-
dependent manner and 10 µM of NK-4 substantially inhibited ThS fluorescence of tau 
aggregation. This result, together with the inhibition of Aǃ aggregation, strongly suggests 
that NK-4 is an effective inhibitor of protein aggregation in vitro. Probably, NK-4 associates 
at the interface of the ǃ-sheet domains of proteins by its planar structure and would thus act 
as a “ǃ-sheet breaker” (Suh & Checler, 2002). 
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(A) Effects of NK-4 on Aǃ fibril formation. Solutions of Aǃ1-40 and Aǃ1-42 (100 µM each) were incubated 
at 37°C for 3 days in the absence or presence of NK-4 at the indicated concentrations. Thioflavin T 
fluorescence was measured. Values are means ± SD (n=3). **P<0.01 vs. control. (B) Electron microscopy 
of Aǃ1-42 fibrils. The solution of 100 µM Aǃ1-42 was incubated for 3 days alone (upper) or with 10 µM of 
NK-4 (lower). Incubated Aǃ was adsorbed on copper grid and negatively stained by uranyl acetate, 
then observed with EM at 80 keV. (C) Effects of NK-4 on tau-352 aggregation. Solutions of tau-352 (15 
µM) were incubated with 2.5 µM of heparin at 37°C in the absence or presence of NK-4 (2.5 or 10 µM) 
and thioflavin S fluorescence was measured. 
Fig. 5. NK-4 inhibits Aǃ fibril formation as well as tau aggregation. 
2.6 Cholinesterase (ChE) inhibitory activity  
As mentioned above, NK-4 showed remarkable neurotrophic and neuroprotective activities 
in vitro, and it might have potential to modulate Aǃ and tau pathologies, which is implicated 
in AD. In relation to a possible application of NK-4 for AD, we examined whether NK-4 has 
an inhibitory effect on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) since 
the progressive deterioration of cholinergic innervation in the cerebral cortex leads to 
cognitive deficits in AD, and AChE inhibitors are still the primary choice for treatment of 
AD (Ellis, 2005). 
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A comparison of IC50 values between NK-4 and other ChE inhibitors suggests that NK-4 is a 
potent and selective inhibitor of AChE (Table 2). The inhibitory effect of NK-4 against AChE 
was weaker than that of donepezil, the most popular drug worldwide for the treatment of 
dementia, but almost comparable to tacrine, and stronger than galantamine (Ohta et al., 
2010a). These results suggest that NK-4 might have potential for the amelioration of 
disturbed cholinergic transmission in AD patients. 
 
Compound 
IC50 (nM) 
AChE BChE Specificity (B/A) 
NK-4 88 ± 2.5 > 6,333 > 70 
Donepezil 6.7 ± 0.35 7,400 ± 130 1100 
Tacrine 77 ± 1.4 69 ± 1.4 0.90 
Galantamine 1,200 ± 33 18,000 ± 333 15 
Inhibitory activities toward AChE and BChE by NK-4 and other ChE inhibitors are shown. IC50 values 
of  NK-4 for AChE and BChE were determined based on the Ellman method using purified enzymes of 
human origin. Other data are cited from a review article (Sugimoto, 2004). Values are means ± SD. 
Table 2. ChE inhibitory activities and specificity of NK-4 and other ChE inhibitors. 
3. Anti-neurodegenerative effects of NK-4 
NK-4 exhibits a neurotrophin-like activity and a potent free radical-scavenging capacity in 
vitro. Moreover, it confers significant stress tolerance to neuronal cells via activation of 
survival signaling pathways. Therefore, we examined whether NK-4 produces effects in 
animal models of neurodegenerative disorders, including models of ischemic stroke, 
cerebellar ataxia, and AD. 
3.1 Stroke model (MCAO Rats) 
Stroke is the second most common cause of death and a major cause of long-lasting 
disability worldwide. In relation to the massive socio-economic impact of ischemic stroke, 
neuroprotective agents with different modes of action and/or extended application time 
windows are therefore urgently needed. We evaluated the effect of NK-4 on ischemic stroke 
using a focal and transient ischemia model in rats. The middle cerebral artery occlusion 
(MCAO) method in rats is an animal model of focal brain ischemia (Bederson et al., 1986) 
frequently used to evaluate drug efficacy.  
In the brains of MCAO rats, infarct volume increased mainly in the ipsilateral cerebral 
cortex and stratum (sites affected by MCAO; Fig. 6B). Administration of NK-4 substantially 
decreased infarct size (Fig. 6C), especially in the cortex penumbra region, a zone of 
incomplete cerebral ischemia. Edaravone also reduced infarct volume by approximately 25% 
compared to the vehicle control, but the difference was not statistically significant (Fig. 6C). 
Regarding the edema ratio, both NK-4 and edaravone significantly attenuated brain 
swelling compared to the vehicle control (Fig. 6D). Although edaravone (1,000 µg/kg) and a 
lower dose of NK-4 (25 µg/kg) failed to significantly reduce infarct size, they still 
significantly decreased brain edema. 
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The rat right middle cerebral artery was occluded by a silicon embolizer for 2-hr and then reperfused 
for 24-hr. Drugs were administered intravenously twice at the indicated doses 1-hr after the occlusion 
and at the start of reperfusion. (A) After the 24-hr reperfusion, neurological impairment scores of rats 
were rated with a maximum impairment score of 6.0. (B) Representative serial brain sections (2 mm 
thickness) stained with 2,3,5-triphenyltetrazolium chloride (TTC) after 2-hr MCAO and 24-hr 
reperfusion. (C) Quantification of hemispheric lesion volumes. Infarct volumes were calculated from 
serial brain sections by Scion Image software. (D) Cerebral edema ratios were calculated based on the 
values from volumetric analysis. NK-4 groups, n=5 each; edaravone group, n=8; control group, n=8. 
Data are means ± S.E.M. *P<0.05, **P<0.01 vs. vehicle control group. Reproduced in part with 
permission from Biological & Pharmaceutical Bulletin Vol.33 No.11. Copyright [2010] Pharmaceutical 
Society of Japan. 
Fig. 6. Suppressive effect of NK-4 on MCAO-induced infarct formation in rats. 
We demonstrated that the efficacy of NK-4 was superior to that of an existing drug 
(edaravone) in scavenging free radicals in vitro (Table 1) and in protecting MCAO model 
rats from brain injury in vivo (Fig. 6). Thus the antioxidative function of NK-4 may foster an 
overall protective environment against neuronal damage after focal brain ischemia. Since 
NK-4 elicits neurotrophic activity in vitro in PC12 cells aside from its antioxidant function, it 
may also enhance endogenous neurotrophic signals in vivo and thereby play an important 
role in the protection of neuronal cells from ischemic damage.  
3.2 Ataxia model (PCD hamsters) 
In the ischemic stroke model, intravenously administered NK-4 showed a significant 
neuroprotective effect (Fig. 6). This model reflects an acute oxidative insult at MCA-affected 
areas in the brain. We next tested the effects of NK-4 on progressive chronic 
neurodegeneration using a genetic ataxia model in the Syrian hamster characterized by 
Purkinje cell degeneration (hmPCD model). This animal model was established in 
HAYASHIBARA Co., Ltd. and is thought to be homologous to the well-characterized pcd 
mutant mice. Both animal models display a suppressed expression of the brain nna1 gene, 
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which encodes a putative zinc carboxypeptidase originally identified by its induction in 
spinal motor neurons during axonal regeneration (Akita & Arai, 2009; Mullen et al., 1997; 
Fernandez-Gonzalez et al., 2002; Harris et al., 2000). Homozygous mutants of hmPCD show 
a moderate ataxia beginning at 7 weeks of age and exhibit an adult-onset degenerative loss 
of cerebellar Purkinje cells (PCs) followed by a slow, mild reduction in granule cell (GC) 
density (Akita et al., 2007). 
To examine the effect of NK-4 on cerebellar ataxia in the hmPCD model, animals were 
administered 20 or 100 µg/kg/day of NK-4 (intraperitoneally) for 8 weeks, starting at 3 
weeks of age. Motor coordination in ataxic and non-ataxic animals was evaluated weekly 
with a rota-rod test. As shown in figure 7A, a low dose of NK-4 (20 µg/kg) elicited a 
moderate, but significant, effect in attenuating the deterioration of motor function. A high 
dose of NK-4 (100 µg/kg) produced a considerable improvement in their rota-rod 
performance that lasted for the entire test period. NK-4 could not halt or reverse the disease 
symptoms in hmPCD, however; it profoundly delayed the progress of disease. At the end of 
the study (10 weeks of age), the motor ability of NK-4-treated animals was evaluated by 
counting the frequency of falling. The hmPCD animals began to fall frequently in their cage  
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(A) Effect of NK-4 on motor performance in the rota-rod test. Animals were tested weekly for the ability 
to remain on the rotating rod at a constant speed (6 rpm), and the time spent on the rod was recorded. 
(B) Effect of NK-4 on frequency of falling in hmPCDs (10 weeks of age). Spontaneous falling of each 
animal was counted for 60 s. (C) Effect of NK-4 on cerebellar size in hmPCDs. The volume of the 
hamster cerebella at 10 weeks of age was calculated as an approximate oval sphere. (D) Effect of NK-4 
on the number of PCs in hmPCDs. PCs were counted in the mid-sagittal section of the cerebellum from 
hmPCDs. (E) GC density in the cerebellum from hmPCDs and wild type controls. H&E stained sections 
of cerebellum cortex from hmPCDs and wild type controls were counted for GCs in an area of 20,000 
µm2. Graphs show the mean ± S.E.M. of 6 hamsters at 10 weeks of age. *P<0.05, **P<0.01 vs. hmPCD 
control. Adapted from Ohta H et al, PLoS ONE 6(2):e17137 (Ohta et al., 2011). 
Fig. 7. Effects of NK-4 on motor coordination and cerebellar degeneration in hmPCDs. 
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from around 7 weeks of age and the frequency of falling increased with age. Animals 
treated with the low and high doses of NK-4 showed a significant reduction in falling 
frequency compared to saline-treated controls (Fig. 7B). These observations demonstrate 
that NK-4 is effective in treating motor discoordination associated with cerebellar ataxia in 
the hmPCD model. 
The mutants also showed severe cerebellar atrophy and volumetric reduction at 10 weeks of 
age (Fig. 7C). Animals treated with low or high doses of NK-4 had a significantly larger 
cerebellum volume compared with saline-treated controls. H&E staining and calbindin 
immunohistochemistry of cerebellar cortical sections revealed a large reduction in the 
number of cerebellar PCs in the brain of hmPCDs at 10 weeks of age (Fig. 7D). The PC 
dendrites in high dose NK-4-treated hmPCDs were significantly longer and thicker than 
those in surviving PCs in saline-treated hmPCDs (data not shown). In the brain of hmPCDs, 
the cerebellar GC density was moderately reduced compared to wild type controls. NK-4 
dose-dependently attenuated cellular atrophy and prevented the reduction in GCs (Fig. 7E). 
In this model, daily intraperitoneal injection of NK-4 at a dose of 20 or 100 µg/kg for 8 
consecutive weeks was effective in attenuating motor discoordination and degenerative loss 
of both PCs and GCs with no detectable adverse events. This suggests that NK-4 can 
attenuate neurodegeneration in the central nervous system via a peripheral route of 
administration. PCs are susceptible to ischemic damage because of their reduced capacity to 
isolate glutamate and reduced ability to generate energy during anoxia (Welsh et al., 2002). 
GCs are also vulnerable to a variety of toxins that decrease glutathione levels and this makes 
the cells more vulnerable to cellular damage from ROS (Fonnum & Lock, 2004). Direct 
scavenging of free radicals by NK-4 may protect these cells. In addition, NK-4 appears to 
activate survival-signaling pathways in degenerating cerebellar neurons.  
3.3 Alzheimer’s Disease (AD) mouse models 
AD, the most common form of dementia, is characterized clinically by ongoing declines in 
cognitive and functional ability and emergence of behavioral and psychological symptoms. 
More than 35 million people living with dementia worldwide in 2010, increasing to 65.7 
million by 2030 and 115.4 million by 2050 (Wimo & Prince, 2010). However, no effective 
disease-modifying therapy is available. A report from Alzheimer’s association predicts the 
total costs of care for AD patients will increase five-fold per year, and the treatments which 
delay the onset of Alzheimer’s disease or slow the progression of this condition dramatically 
reduce the costs of Medicare or Medicaid (Alzheimer’s association, 2010). Presently, the only 
approved therapies for AD are ChE inhibitors and an N-methyl-D-aspartate (NMDA) receptor 
antagonist, and the beneficial effects of these symptomatic treatments appear limited and are 
not long lasting (Lanctôt et al., 2009). Thus, more evidence-based effective therapies, whether 
they are symptomatic treatment or disease-modifying strategies, are urgently needed.  
NK-4 shows potent neuroprotective and neurotrophin-like activities in vitro (Fig. 1~3) and 
also in vivo (Fig. 6, 7). Furthermore, it remarkably and selectively inhibits AChE in vitro 
(Table 2). These multiple properties of NK-4 raised the possibility that it could halt or slow 
the progression of AD. To date, several mouse models for AD based on the amyloid 
hypothesis or the tau hypothesis have been developed (Bloom et al., 2005). Therefore, we 
tested the potential effects of NK-4 on AD using in vivo studies incorporating the amyloid 
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precursor protein (APP) transgenic mice Tg2576 (Hsiao et al., 1996) and the Aǃ-induced 
amnesia model (Maurice et al., 1996). 
3.3.1 Effects of NK-4 in APP-Tg (Tg2576) mice 
The Tg2576 mouse is the most thoroughly characterized AD mouse model and is considered 
to reflect human amyloid pathology most closely among mouse models. This mouse 
develops a considerable amount of Aǃ deposits in the brain with age and this is 
accompanied by gradual declines in cognitive function (Hsiao, 2001). We examined whether 
chronic administration of NK-4 produced an effect on the cognitive deficits in Tg2576 mice 
(Ohta et al., 2010b). Tg2576 mice were administered NK-4 as doses of 100 or 500 µg/kg/day 
once a day, 5 times a week for 9 months, starting at 3 months of age. Donepezil, an existing 
drug for dementia based on its AChE inhibitory properties (Sugimoto, 2004) was used as a 
control drug and was administered at a dose of 200 µg/kg/day. 
Wild type and Tg2576 mice were tested for spatial learning ability in a Morris water maze 
test (Morris, 1984) at ages 6 and 12 months. There were significant differences in escape 
latency between the wild type controls and saline-treated Tg2576 mice at 6 and 12 months of 
age (Fig. 8A). For the saline-treated Tg2576 group, the latency to reach the hidden platform 
did not shorten during the whole test period at 12 months of age, suggesting that the spatial 
learning ability of saline-treated Tg2576 mice became impaired with age. We found 
significant differences in spatial learning ability between the NK-4-treated Tg2576 mice (at 
both low and high doses) and saline-treated Tg2576 mice. Saline-treated Tg2576 mice 
consistently exhibited longer escape latencies compared to the NK-4-treated Tg2576 group 
at 6 and 12 months of age. Donepezil-treated mice showed a partial improvement in spatial 
memory deficits at 6 months of age, although the drug became less effective over time. At 12 
months of age, the escape latencies of donepezil-treated and saline-treated Tg2576 mice 
showed no significant difference. These results suggest a long-lasting ameliorative effect of 
NK-4 on Aǃ-mediated spatial memory impairment. 
We also evaluated the object recognition memory of Tg2576 mice in a novel object 
recognition test (Nagai et al., 2003). Long-term recognition memory was tested at ages of 6, 
9, and 12 months (Fig. 8B). Saline-treated Tg2576 mice displayed significantly decreased 
object recognition memory compared to wild type mice at the same ages. Tg2576 mice 
treated with low and high doses of NK-4 or donepezil spent a longer time exploring the 
novel object than did the saline-treated controls at 6 months of age. However, at 9 and 12 
month of age, the exploration preference values of low dose NK-4 and donepezil-treated 
groups decreased, and the differences between these two groups and saline-treated group 
became insignificant. In contrast, the high dose of NK-4 group spent a significantly longer 
time exploring the novel object versus the saline-treated mice throughout the test period, 
and the exploratory preference was comparable to that of wild type controls at 12 months of 
age. This suggests that NK-4 administration for a longer period and at high dosing might be 
more effective for the improvement of object recognition memory. 
At the end of experiment (12 months of age; after 9-month treatment), the effects of NK-4 on 
plasma and brain Aǃ levels in Tg2576 mice were evaluated (Fig. 9). Dose-dependent 
increases in Aǃ1-40 and Aǃ1-42 were observed in plasma from the NK-4-treated mice (Fig. 9A). 
Although donepezil treatment also increased both plasma Aǃ1-40 and Aǃ1-42 levels, the effect 
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was lower compared to NK-4 treatments. Brain levels of Aǃ were estimated separately in 
detergent-insoluble and -soluble fractions. Both detergent-insoluble and soluble Aǃ1-40 levels 
were significantly decreased by NK-4 treatment (Fig. 9B, upper graphs). Donepezil did not 
affect Aǃ concentrations in brain. Because the levels of Aǃ1-42 were very low in all groups 
compared to those of Aǃ1-40 (Fig. 9B, lower graphs), the levels of Aǃ1-40 seem to reflect the 
total amount of Aǃ in the brain.  
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NK-4 was injected intraperitoneally to Tg2576 mice at a dose of 100 or 500 µg/kg once a day, five 
times a week for 9 months, beginning at 3 months of age (n=10 each). Donepezil (DPZ) was 
administered at a dose of 200 µg/kg (n=5). Control mice received 200 µl of saline (wild type, n=10; 
Tg2576, n=10). (A) Morris water maze test at 6 and 12 months of age. The escape latency represents 
the average time to find a hidden platform placed in a fixed location in a circular pool (ø130 cm). 
Two trials per day were conducted for 4 consecutive days with an upper cutoff time of 120 sec. (B) 
Novel object recognition test at 6, 9 and 12 months of age. Two objects X and Y were placed in the 
test box and the exploration behavior of mice was recorded. A retention session was performed 24 hr 
after the training session. One of the familiar objects Y was replaced by a novel object Z. Mice were 
allowed to explore freely for 10 min, with the time spent in exploring each of the two objects 
recorded. The exploratory preference was expressed as a ratio of the time spent exploring the novel 
object (TZ) over that spent on the two objects (TX+TZ). Data are expressed as means ± S.E.M. *P<0.05, 
**P<0.01 vs. saline-treated Tg2576 group. Wild: non-transgenic mice. Tg(saline), saline-treated 
Tg2576 mice; Tg(DPZ), donepezil-treated Tg2576 mice; Tg(NK-4: 100), low-dose NK-4-treated Tg2576 
mice; Tg2576 (NK-4: 500), high-dose NK-4-treated Tg2576 mice. 
Fig. 8. Effect of NK-4 on recognition memory in Tg2576 mice. 
We next surveyed brain Aǃ deposition in Tg2576 mice by Aǃ immunohistochemistry (Fig. 
9C). Aǃ-immunoreactive small diffuse plaques were abundantly present in the cortex of 
saline-treated Tg2576 mice (upper panel), and they were visibly reduced by high dose NK-4 
treatment both in size and in quantity (bottom panel). The donepezil-treated group showed 
a slight decrease in Aǃ-immunoreactivity (middle panel). 
Nine months of NK-4 administration to Tg2576 mice significantly attenuated the cognitive 
decline as assessed by behavioral tests (Fig. 8), and decreased the levels of Aǃ in the brain 
(Fig. 9B, C) while augmenting levels in the plasma (Fig. 9A). These results imply that NK-4-
induced cognitive improvement was attributable to decreased Aǃ brain levels. Although 
there is still no consensus as to the mechanism by which some drugs, including anti-Aǃ 
antibodies, alter amyloid deposition in the brain (Levites et al., 2006), Aǃ may be cleared 
across the blood-brain barrier to the blood in NK-4-treated Tg2576 mice.  
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(A) Plasma Aǃ concentrations of Tg2576 mice at 12 months of age. Aǃ levels were separately 
measured by ELISA for Aǃ1-40 and Aǃ1-42. (B) Brain Aǃ levels of detergent-insoluble or soluble 
fractions at 12 months of age. Hemi-brains from Tg2576 mice were homogenized and separated into 
detergent-insoluble and soluble fractions. Aǃ1-40 and Aǃ1-42 in individual samples were measured and 
are expressed as picomoles/g wet brain weight. Values are the means ± S.E.M. Saline (Sal), n=10; 
Donepezil (DPZ), n=5; NK-4 (100), n=9; and NK-4 (500), n=8. *P<0.05, **P<0.01 vs. saline-treated 
group. (C) Aǃ-immunohistochemistry of the cerebral cortex from Tg2576 mice at 12 months of age. 
Hemi-brains were fixed with 10% buffered formalin and embedded in paraffin. Coronal sections of 
cerebral cortex with 5-µm thickness were immunostained with rabbit anti-Aǃ-peptide polyclonal 
antibody. Bar represents 50-µm. 
Fig. 9. Effect of NK-4 on the plasma and brain concentrations of Aǃ in Tg2576 mice. 
Oxidative mechanisms are thought to be involved in cell loss and other neuropathologies 
associated with AD (Zhu et al., 2001; Cutler et al., 2004). During AD pathogenesis, ROS 
impair mitochondrial redox activity and further increase ROS generation (Shearman et al., 
1994; Hensley et al., 1994). Aǃ induces the production of ROS and leads to apoptotic 
neuronal cell death that can be inhibited by antioxidants (Behl et al., 1994; Mattson & 
Goodman, 1995). Pathological and biochemical studies suggest that ROS induced by fibrillar 
Aǃ produce neurotoxic effects (Gevais et al., 1999). Since NK-4 is a potent scavenger of ROS 
(Table 1) and is an inhibitor of Aǃ aggregation (Fig. 2), these features might work in concert 
to attenuate Aǃ toxicity in AD. 
3.3.2 Effects of NK-4 in Aβ-icv mice 
To further determine whether the effect of NK-4 was directly attributable to mitigation of 
Aǃ pathology, an Aǃ-induced amnesia model was employed (Ohta et al., 2010a). In this 
model, ICR mice received intracerebroventricular (icv) administration of aggregated Aǃ25-35 
peptide to induce memory deficits due to cholinergic dysfunction (Maurice et al., 1996). 
Long-term recognition memory was evaluated by the step-through type passive avoidance 
test 12 days after Aǃ25-35 injection. In this behavioral assay, daily NK-4 treatment 
significantly and dose-dependently improved memory deficits induced by Aǃ25-35 (Fig. 10A). 
There was a significant difference in step-through latencies between sham operated mice 
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and Aǃ25-35-injected ICR mice. Both low (50 µg/kg) and high (500 µg/kg) doses of NK-4 
successfully prolonged the step-through latencies with statistically significant differences 
(p<0.05 for the low dose and p<0.01 for the high dose, respectively; Fig. 10A). Improved 
long-term memory retention following NK-4 administration was also confirmed using this 
animal model in a novel object recognition test (data not shown). 
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(A) Passive avoidance test of Aǃ25-35–icv mice. Male ICR mice were injected aged Aǃ25-35 (9 nmol/mouse) 
into the left lateral ventricle using the following coordinates from Bregma: 0.5 mm posterior, 1.0 mm 
lateral, and 2.0 mm ventral. A low (50 μg/kg) or high (500 μg/kg) dose of NK-4 was administered 
intraperitoneally to mice for twelve consecutive days starting from the next day of Aǃ injection. Then, 
mice were tested for step-through passive avoidance during days 9-12. The step-through latency in the 
retention session (24-hr after the training session) was recorded. Values are means ± S.E.M. (n=10). 
Sham, sham-operated group; saline, saline-treated Aǃ25-35–icv group; NK-4, NK-4-treated Aǃ25-35–icv 
groups. *P<0.05, **P<0.01 vs. saline-treated group. (B) Histological damage scores in the hippocampal 
CA1 region. Hippocampal neuronal cell loss was assessed in coronal H&E sections. Scores are 
represented as means ± S.E.M. (n=10). Arrows indicate the sites of degeneration. 
Fig. 10. Effects of NK-4 on Aǃ25-35-induced cognitive impairments in ICR mice. 
These beneficial effects of NK-4 on recognition memory are in agreement with histological 
findings shown in figure 10B. A single icv injection of Aǃ25-35 caused significant 
hippocampal neuronal loss mainly in the CA1 region. The difference in histological scores 
was not statistically significant between the saline-treated (1.6 ± 0.41) and the high dose NK-
4–treated mice (0.9 ± 0.41, p = 0.067). However, NK-4 ameliorated the Aǃ25-35-induced injury 
of pyramidal neurons in the hippocampus (Fig. 10B). Reportedly, associative learning in the 
passive avoidance test strongly depends on hippocampal function (Phillips & LeDoux, 
1992). In this context, neuronal injury in the hippocampal CA1 region following Aǃ25-35-icv 
injection provides a reasonable explanation for the impaired long-term memory. These 
results, in combination with the results from Tg2576 mice, and AChE inhibitory property of 
NK-4 suggest that NK-4 treatment effectively improves cognitive deficits in AD model mice 
by both attenuating Aǃ pathology and enhancing cholinergic transmission in the brain. 
4. Conclusion 
In this chapter, we showed that NK-4, a type of cyanine dye, exerts a wide spectrum of 
biochemical and biological activities implicated in neuroprotection. NK-4 significantly 
ameliorated neurological and cognitive deficits, as well as neurodegeneration, in four 
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distinct animal models (MCAO rats, ataxic hamsters, APP-transgenic mice, and Aǃ-icv 
mice). Molecular mechanisms by which NK-4 acts against neurodegeneration remain 
unclear, although it was found that NK-4 activates the PI3K-Akt pathway independently of 
Trk receptors. Thus, activated Akt may be a key mediator of the beneficial effects on neural 
cell survival. In addition, since activated Akt is required for PI3K-mediated synaptic 
plasticity and memory consolidation via activation of the downstream regulator CREB 
(Brightwell et al., 2007), induction of Akt phosphorylation might play a critical role in NK-4-
mediated memory improvement in animal models of dementia. In addition to the 
modification of intracellular signaling, a direct antioxidative property of NK-4 may also be 
involved in survival and functional maintenance of neurons. 
Regarding the safety profile, there were no specific adverse events in mice that received 
intraperitoneal injections of NK-4 at doses of up to 500 µg/kg/day, 5 days a week, for 9 
months (3.3.1. Tg2576 study). Furthermore, NK-4 was well tolerated in rats up to 4,000 
mg/kg in an acute toxicity study and 100 mg/kg in a subacute toxicity study (both via the 
oral rout of administration) based on mortality, clinical observations, body weight, 
hematology, blood chemistry, organ weights, and histological examination of a complete 
tissue list (Ohmori et al., 1983). Furthermore, NK-4 has been used as an active ingredient of 
over the counter (OTC) medicine in Japan for treating allergy, and for promoting wound 
healing since the 1950s (Suzue, 1969). Additionally, NK-4 was not mutagenic in the standard 
Ames test (our unpublished data). These observations suggest that NK-4 is a safe compound 
that will not cause serious adverse reactions.  
Application of small neurotrophic molecules that modulate neuronal survival and synaptic 
function is a promising and valid therapeutic approach for neurodegenerative disorders. Lines 
of evidence described here strongly suggest the potential utility of NK-4 as a treatment for 
neurodegenerative disease. The evaluations of pharmacokinetics, bioavailability, as well as the 
efficacy of orally administered NK-4 are ongoing. In addition, assessment of NK-4 in human 
neurodegenerative therapy will require further studies. 
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